Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...
RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
RNA is a central biological macromolecule, now widely harnessed in medicine and nanotechnology. Like proteins, RNA function ...
18hon MSN
Asteroid hurtling toward Earth found to be teeming with building blocks of life: researchers
Scientists discovered ribose — in addition to “all five nucleobases used to construct both DNA and RNA” — on asteroid Bennu, ...
Scientists have sequenced RNA from a nearly 40,000-year-old woolly mammoth leg, the oldest ancient RNA ever recovered. These ...
Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...
In a study published in Science Translational Medicine, researchers at Cedars-Sinai report that an experimental drug called TY1 helped damaged hearts heal in laboratory animals. It did not thin blood ...
A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...
Researchers have used cryo-EM and computational tools to visualize ribozyme assembly, shedding light on life's most versatile ...
Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback